Bleichroeder’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.2M Hold
100,000
– – 0.32% 56
2026
Q2
$3.87M Buy
+100,000
New +$3.5M 0.69% 23

Other funds holding COGT

Bleichroeder's COGT Position: Q3 2026 in Review

Bleichroeder held its Cogent Biosciences (COGT) position steady in Q3 2026 at 100,000 shares worth $3.2M. The position accounts for 0.32% of the portfolio, ranked #56.

Bleichroeder first reported a position in COGT in Q2 2026 and has held it in 2 quarters since. The position peaked at $3.87M in Q2 2026. 202 funds tracked by Wall St. Rank hold COGT as of Q3 2026.

  • Bleichroeder held 100,000 shares of Cogent Biosciences worth $3.2M as of Q3 2026.
  • Bleichroeder left its Cogent Biosciences share count unchanged in Q3 2026.
  • Cogent Biosciences made up 0.32% of Bleichroeder's portfolio in Q3 2026, its #56 holding.
  • Bleichroeder first reported a position in Cogent Biosciences in Q2 2026 and has held it in 2 quarters since.
  • Bleichroeder's Cogent Biosciences position peaked at $3.87M in Q2 2026.
  • 202 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.

Based on Bleichroeder's 13F filing for Q3 2026, filed 13 Nov 2026.